|Expected size of offer (M):||£2m|
|Expected first date of trading:||24/04/2014|
|Location of address at which admission document will be available:||A copy of the Company's Admission Document is available for download from the Company's website at www.ad-investments.com and following Admission and change of name at www.tizianalifesciences.com The Admission Document contains full details about the applicant and the admission of its securities.|
|Date at which admission document will be available:||-|
|Nominated Advisor (AIM Companies):||Cairn Financial Advisers LLP|
|Nominated Broker (AIM Companies):||Beaufort Securities Limited|
|Christopher William Rourke||Non-Executive Chairman|
|Percy William Cecil Lomax||Non-Executive Director|
|David Alexander Hill Scott||Non-Executive Director|
|Andrew Mark Gutmann||Non-Executive Director|
|Gabriele Marco Antonio Cerrone||Executive Chairman|
|Philip James Boyd||Finance Director|
|Riccardo Dalla-Favera||Non-Executive Director|
|Fiscal year end:||31 December|
|Website URL:||www.ad-investments.com To be changed following Admission and change of name to: www.tizianalifesciences.com|
The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.
You will be redirected in five seconds.
You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.
The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.
You will be redirected in five seconds